QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
NASDAQ:QIPT - CA74880P1045 - Common Stock
2.6 USD
+0.01 (+0.39%)
We assign a fundamental rating of 3 out of 10 to QIPT. QIPT was compared to 101 industry peers in the Health Care Providers & Services industry. QIPT has a bad profitability rating. Also its financial health evaluation is rather negative. QIPT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIPT has reported negative net income.
In the past year QIPT had a positive cash flow from operations.
QIPT had negative earnings in 4 of the past 5 years.
Each year in the past 5 years QIPT had a positive operating cash flow.
1.2 Ratios
QIPT's Return On Assets of -4.35% is on the low side compared to the rest of the industry. QIPT is outperformed by 64.36% of its industry peers.
With a Return On Equity value of -10.01%, QIPT perfoms like the industry average, outperforming 43.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| ROIC | N/A |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 71.51%, QIPT belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for QIPT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
QIPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
QIPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, QIPT has more shares outstanding
The debt/assets ratio for QIPT is higher compared to a year ago.
2.2 Solvency
QIPT has an Altman-Z score of 0.40. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.40, QIPT is doing worse than 75.25% of the companies in the same industry.
The Debt to FCF ratio of QIPT is 5.81, which is a neutral value as it means it would take QIPT, 5.81 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.81, QIPT is in the better half of the industry, outperforming 63.37% of the companies in the same industry.
A Debt/Equity ratio of 0.71 indicates that QIPT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, QIPT is in line with its industry, outperforming 50.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.81 | ||
| Altman-Z | 0.4 |
ROIC/WACCN/A
WACC8.13%
2.3 Liquidity
QIPT has a Current Ratio of 1.15. This is a normal value and indicates that QIPT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.15, QIPT is doing worse than 65.35% of the companies in the same industry.
QIPT has a Quick Ratio of 1.15. This is a bad value and indicates that QIPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QIPT has a Quick ratio of 0.75. This is in the lower half of the industry: QIPT underperforms 79.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -90.91%.
QIPT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.21%.
The Revenue has been growing by 32.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
3.2 Future
Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 97.77% on average per year.
QIPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.85% yearly.
EPS Next Y-53%
EPS Next 2Y-33.6%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue Next Year-6.9%
Revenue Next 2Y8.99%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
92.08% of the companies in the same industry are more expensive than QIPT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaply inside the industry as 92.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.1 | ||
| EV/EBITDA | 5.32 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.6%
EPS Next 3Y2.12%
5. Dividend
5.1 Amount
QIPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:QIPT (9/8/2025, 12:21:09 PM)
2.6
+0.01 (+0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners45.65%
Inst Owner Change-20.08%
Ins Owners15.15%
Ins Owner Change53.95%
Market Cap112.94M
Analysts80
Price Target3.73 (43.46%)
Short Float %2.53%
Short Ratio1.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-9.06%
Max Revenue beat(2)-0.65%
Revenue beat(4)0
Avg Revenue beat(4)-8.24%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-0.65%
Revenue beat(8)0
Avg Revenue beat(8)-5.71%
Revenue beat(12)1
Avg Revenue beat(12)-4.96%
Revenue beat(16)2
Avg Revenue beat(16)-4.19%
PT rev (1m)-28.3%
PT rev (3m)-42.11%
EPS NQ rev (1m)44.45%
EPS NQ rev (3m)-433.3%
EPS NY rev (1m)-125%
EPS NY rev (3m)-125%
Revenue NQ rev (1m)9%
Revenue NQ rev (3m)-1.76%
Revenue NY rev (1m)2.63%
Revenue NY rev (3m)-3.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.49 | ||
| P/FCF | 7.1 | ||
| P/OCF | 3.78 | ||
| P/B | 1.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.32 |
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.37
FCFY14.09%
OCF(TTM)0.69
OCFY26.47%
SpS5.29
BVpS2.36
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.35% | ||
| ROE | -10.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.51% | ||
| FCFM | 6.93% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.81 | ||
| Debt/EBITDA | 2 | ||
| Cap/Depr | 33.78% | ||
| Cap/Sales | 6.09% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 81.97% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.15 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | 0.4 |
F-Score3
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y-53%
EPS Next 2Y-33.6%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
Revenue Next Year-6.9%
Revenue Next 2Y8.99%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
EBIT growth 1Y-209.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1615.9%
EBIT Next 3Y157.9%
EBIT Next 5Y154.85%
FCF growth 1Y-39.09%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y-12.62%
OCF growth 3Y23.7%
OCF growth 5Y33.42%